Long Term Debt Summary of Ginwa Enterprise (Group) Inc.

Ginwa Enterprise (Group) Inc.'s latest annual long term debt in 2023 was 5.42 Million CNY , down -53.58% from previous year.
Ginwa Enterprise (Group) Inc.'s latest quarterly long term debt in 2024 Q2 was 9.73 Million CNY , down 0.0% from previous quarter.
Ginwa Enterprise (Group) Inc. reported annual long term debt of 11.69 Million CNY in 2022, up 156985255683686500.0% from previous year.
Ginwa Enterprise (Group) Inc. reported annual long term debt of - CNY in 2021, down 0.0% from previous year.
Ginwa Enterprise (Group) Inc. reported quarterly long term debt of 9.73 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Ginwa Enterprise (Group) Inc. reported quarterly long term debt of 9.8 Million CNY for 2024 Q3, up 100.0% from previous quarter.

Annual Long Term Debt Chart of Ginwa Enterprise (Group) Inc. (2023 - 1994)

Historical Annual Long Term Debt of Ginwa Enterprise (Group) Inc. (2023 - 1994)

Year	Long Term Debt	Long Term Debt Growth
2023	5.42 Million CNY	-53.58%
2022	11.69 Million CNY	156985255683686500.0%
2021	- CNY	0.0%
2020	- CNY	-100.0%
2019	50 Million CNY	0.0%
2018	- CNY	0.0%
2017	- CNY	0.0%
2016	- CNY	0.0%
2015	- CNY	-100.0%
2014	1.00 CNY	0.0%
2013	- CNY	0.0%
2012	- CNY	0.0%
2011	- CNY	0.0%
2010	- CNY	0.0%
2009	- CNY	0.0%
2008	- CNY	0.0%
2007	- CNY	-100.0%
2006	55.72 Million CNY	-67.51%
2005	171.48 Million CNY	9.06%
2004	157.24 Million CNY	109.65%
2003	75 Million CNY	25.0%
2002	60 Million CNY	200.0%
2001	20 Million CNY	-77.01%
2000	87 Million CNY	325.43%
1999	20.45 Million CNY	0.0%
1998	20.45 Million CNY	0.0%
1997	- CNY	-100.0%
1996	47.59 Million CNY	0.0%
1995	- CNY	0.0%
1994	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	6.94 Million CNY	0.0%
2024 Q2	9.73 Million CNY	0.0%
2024 Q3	9.8 Million CNY	100.0%
2023 Q1	11.88 Million CNY	1.62%
2023 Q2	8.35 Million CNY	-29.73%
2023 FY	5.42 Million CNY	-53.58%
2023 Q3	8.04 Million CNY	-3.63%
2023 Q4	5.42 Million CNY	-32.55%
2022 Q1	1.00 CNY	13421772900.0%
2022 FY	11.69 Million CNY	156985255683686500.0%
2022 Q4	11.69 Million CNY	-3.96%
2022 Q3	12.17 Million CNY	0.0%
2022 Q2	- CNY	-100.0%
2021 Q2	- CNY	0.0%
2021 Q1	- CNY	0.0%
2021 FY	- CNY	0.0%
2021 Q4	- CNY	0.0%
2021 Q3	- CNY	0.0%
2020 Q1	50 Million CNY	0.0%
2020 Q3	50 Million CNY	0.0%
2020 Q4	- CNY	-100.0%
2020 FY	- CNY	-100.0%
2020 Q2	50 Million CNY	0.0%
2019 Q1	- CNY	0.0%
2019 FY	50 Million CNY	0.0%
2019 Q4	50 Million CNY	0.0%
2019 Q2	- CNY	0.0%
2019 Q3	- CNY	0.0%
2018 Q4	- CNY	0.0%
2018 Q3	- CNY	0.0%
2018 FY	- CNY	0.0%
2018 Q2	- CNY	0.0%
2018 Q1	- CNY	0.0%
2017 Q2	- CNY	0.0%
2017 FY	- CNY	0.0%
2017 Q4	- CNY	0.0%
2017 Q3	- CNY	0.0%
2017 Q1	- CNY	0.0%
2016 Q2	- CNY	0.0%
2016 Q1	- CNY	0.0%
2016 FY	- CNY	0.0%
2016 Q4	- CNY	0.0%
2016 Q3	- CNY	0.0%
2015 Q4	- CNY	0.0%
2015 Q1	- CNY	-100.0%
2015 Q2	- CNY	0.0%
2015 FY	- CNY	-100.0%
2015 Q3	- CNY	0.0%
2014 Q2	- CNY	0.0%
2014 Q4	1.00 CNY	0.0%
2014 FY	1.00 CNY	0.0%
2014 Q1	- CNY	0.0%
2014 Q3	- CNY	0.0%
2013 Q3	- CNY	0.0%
2013 Q4	- CNY	0.0%
2013 FY	- CNY	0.0%
2013 Q1	- CNY	0.0%
2013 Q2	- CNY	0.0%
2012 Q3	- CNY	0.0%
2012 FY	- CNY	0.0%
2012 Q4	- CNY	0.0%
2012 Q1	- CNY	0.0%
2012 Q2	- CNY	0.0%
2011 Q4	- CNY	0.0%
2011 Q3	- CNY	0.0%
2011 Q2	- CNY	0.0%
2011 Q1	- CNY	0.0%
2011 FY	- CNY	0.0%
2010 Q1	- CNY	0.0%
2010 FY	- CNY	0.0%
2010 Q4	- CNY	0.0%
2010 Q3	- CNY	0.0%
2010 Q2	- CNY	0.0%
2009 Q4	- CNY	0.0%
2009 Q1	- CNY	0.0%
2009 FY	- CNY	0.0%
2009 Q2	- CNY	0.0%
2009 Q3	- CNY	0.0%
2008 Q2	- CNY	0.0%
2008 Q1	- CNY	0.0%
2008 FY	- CNY	0.0%
2008 Q4	- CNY	0.0%
2008 Q3	- CNY	0.0%
2007 Q4	- CNY	-100.0%
2007 FY	- CNY	-100.0%
2007 Q1	55.72 Million CNY	0.0%
2007 Q2	15 Million CNY	-73.08%
2007 Q3	15 Million CNY	0.0%
2006 FY	55.72 Million CNY	-67.51%
2006 Q4	55.72 Million CNY	-67.51%
2006 Q3	171.48 Million CNY	0.0%
2006 Q2	171.48 Million CNY	0.0%
2006 Q1	171.48 Million CNY	0.0%
2005 FY	171.48 Million CNY	9.06%
2005 Q4	171.48 Million CNY	-3.25%
2005 Q3	177.24 Million CNY	-2.54%
2005 Q2	181.86 Million CNY	15.66%
2005 Q1	157.24 Million CNY	0.0%
2004 Q3	158 Million CNY	0.0%
2004 FY	157.24 Million CNY	109.65%
2004 Q2	158 Million CNY	110.67%
2004 Q1	75 Million CNY	0.0%
2004 Q4	157.24 Million CNY	-0.48%
2003 Q3	60 Million CNY	0.0%
2003 Q4	75 Million CNY	25.0%
2003 Q2	60 Million CNY	-45.45%
2003 Q1	110 Million CNY	83.33%
2003 FY	75 Million CNY	25.0%
2002 Q2	97 Million CNY	385.0%
2002 Q4	60 Million CNY	-38.14%
2002 FY	60 Million CNY	200.0%
2002 Q1	20 Million CNY	0.0%
2002 Q3	97 Million CNY	0.0%
2001 Q4	20 Million CNY	0.0%
2001 Q2	87 Million CNY	0.0%
2001 FY	20 Million CNY	-77.01%
2000 Q2	20 Million CNY	0.0%
2000 Q4	87 Million CNY	0.0%
2000 FY	87 Million CNY	325.43%
1999 Q2	20.45 Million CNY	0.0%
1999 FY	20.45 Million CNY	0.0%
1999 Q4	20.45 Million CNY	0.0%
1998 FY	20.45 Million CNY	0.0%
1998 Q4	20.45 Million CNY	0.0%
1998 Q2	20.45 Million CNY	0.0%
1997 Q2	- CNY	0.0%
1997 FY	- CNY	-100.0%
1997 Q4	- CNY	0.0%
1996 FY	47.59 Million CNY	0.0%
1995 FY	- CNY	0.0%
1994 FY	- CNY	0.0%

Peer Long Term Debt Comparison of Ginwa Enterprise (Group) Inc.

Name	Long Term Debt	Long Term Debt Difference
China Animal Husbandry Industry Co., Ltd.	899.03 Million CNY	99.396%
Guangxi Wuzhou Zhongheng Group Co.,Ltd	553.47 Million CNY	99.019%
Yabao Pharmaceutical Group Co., Ltd	3.36 Million CNY	-61.148%
ZhuZhou QianJin Pharmaceutical Co.,Ltd	38.46 Million CNY	85.884%
Tianjin Tianyao Pharmaceuticals Co., Ltd.	277 Million CNY	98.04%
Kangmei Pharmaceutical Co., Ltd.	188.16 Million CNY	97.115%
Tasly Pharmaceutical Group Co., Ltd	1.41 Billion CNY	99.616%
Jiangsu Kanion Pharmaceutical Co.,Ltd.	1.92 Million CNY	-181.974%
Hubei Jumpcan Pharmaceutical Co., Ltd.	1.43 Million CNY	-278.507%
Shandong Lukang Pharmaceutical Co.,Ltd.	1.3 Billion CNY	99.585%
North China Pharmaceutical Company Ltd.	4.08 Billion CNY	99.867%
Zhejiang Shengda Bio-Pharm Co., Ltd.	144 Million CNY	96.23%
Zhejiang Starry Pharmaceutical Co.,Ltd.	734.44 Million CNY	99.261%
Heilongjiang ZBD Pharmaceutical Co., Ltd.	1.29 Billion CNY	99.582%
Shandong Buchang Pharmaceuticals Co., Ltd.	2.09 Billion CNY	99.741%
Dali Pharmaceuticalco.,Ltd	14.84 Million CNY	63.437%
Guobang Pharma Ltd.	451.7 Million CNY	98.798%
ChengDu ShengNuo Biotec Co.,Ltd.	189.19 Million CNY	97.13%
Changchun BCHT Biotechnology Co.	-9.85 Million CNY	155.086%
Shanghai Haoyuan Chemexpress Co., Ltd.	229.23 Million CNY	97.631%
Zhejiang Huahai Pharmaceutical Co., Ltd.	4.02 Billion CNY	99.865%
Harbin Pharmaceutical Group Co., Ltd.	32.62 Million CNY	83.36%
Zhejiang Medicine Co., Ltd.	230.54 Million CNY	97.645%
HPGC Renmintongtai Pharmaceutical Corporation	29.4 Million CNY	81.538%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited	241.03 Million CNY	97.747%
Lionco Pharmaceutical Group Co.,Ltd.	445.18 Million CNY	98.78%
Humanwell Healthcare (Group) Co.,Ltd.	1.65 Billion CNY	99.671%
KPC Pharmaceuticals, Inc.	107.56 Million CNY	94.952%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.	70.75 Million CNY	92.326%
Jiangsu Jibeier Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Ningbo Menovo Pharmaceutical Co., Ltd.	759.64 Million CNY	99.285%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd	389.05 Million CNY	98.604%
Nanjing Well Pharmaceutical Group Co.,Ltd.	104.06 Million CNY	94.783%
Henan Lingrui Pharmaceutical Co., Ltd.	6.96 Million CNY	22.015%
Joincare Pharmaceutical Group Industry Co.,Ltd.	3.12 Billion CNY	99.826%
China Resources Double-Crane Pharmaceutical Co.,Ltd.	29.94 Million CNY	81.872%
Chongqing Taiji Industry(Group) Co.,Ltd	341.6 Million CNY	98.411%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited	3.32 Billion CNY	99.837%
China National Medicines Corporation Ltd.	205.07 Million CNY	97.353%
Shenzhen Chipscreen Biosciences Co., Ltd.	1.02 Billion CNY	99.469%
Guizhou Yibai Pharmaceutical Co., Ltd.	387.22 Million CNY	98.598%
Zhongzhu Healthcare Holding Co.,Ltd	12.76 Million CNY	57.465%
Beijing Tongrentang Co., Ltd	1.42 Billion CNY	99.62%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	10.95 Million CNY	50.429%
Jianmin Pharmaceutical Group Co.,Ltd.	30.29 Million CNY	82.078%
Tibet Weixinkang Medicine Co., Ltd.	3.81 Million CNY	-42.174%
CanSino Biologics Inc.	1.07 Billion CNY	99.495%
Zhejiang Hisun Pharmaceutical Co., Ltd.	2.39 Billion CNY	99.774%
Shanghai Jiaoda Onlly Co.,Ltd	120.22 Million CNY	95.484%
Jiang Zhong Pharmaceutical Co.,Ltd	1.04 Million CNY	-418.219%
Mayinglong Pharmaceutical Group Co., LTD.	128.45 Million CNY	95.773%
Cisen Pharmaceutical Co., Ltd.	132.53 Million CNY	95.903%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.	316.84 Million CNY	98.286%
Hunan Warrant Pharmaceutical Co.,Ltd	17.1 Million CNY	68.261%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	13.5 Billion CNY	99.96%
Hunan Fangsheng Pharmaceutical Co., Ltd.	174 Million CNY	96.88%
Shaanxi Kanghui Pharmaceutical Co., Ltd.	283.87 Million CNY	98.087%
Henan Taloph Pharmaceutical Stock Co.,Ltd	183.8 Million CNY	97.046%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd	512.37 Million CNY	98.94%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	40.62 Million CNY	86.635%
Shanghai Shyndec Pharmaceutical Co., Ltd.	1.03 Billion CNY	99.473%
Shanghai Yizhong Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Tibet Rhodiola Pharmaceutical Holding Co.	1.12 Million CNY	-382.428%
Sichuan Huiyu Pharmaceutical Co., Ltd.	2.04 Million CNY	-165.066%
Jiangsu Lianhuan Pharmaceutical Co., Ltd.	82.91 Million CNY	93.452%

Global Stocks Search

Ginwa Enterprise (Group) Inc. (600080.SS)

Long Term Debt Summary of Ginwa Enterprise (Group) Inc.

Annual Long Term Debt Chart of Ginwa Enterprise (Group) Inc. (2023 - 1994)

Historical Annual Long Term Debt of Ginwa Enterprise (Group) Inc. (2023 - 1994)

Peer Long Term Debt Comparison of Ginwa Enterprise (Group) Inc.